Brief: Nevro Announces Consensus Statement Supporting High-Frequency Spinal Cord Stimulation Therapy For Refractory Painful Diabetic Neuropathy
01/02/2024 22:35
Feb 1 (Reuters) - Nevro Corp NVRO.N :
* NEVRO ANNOUNCES CONSENSUS STATEMENT SUPPORTING
HIGH-FREQUENCY
(10 KHZ) SPINAL CORD STIMULATION THERAPY FOR REFRACTORY PAINFUL
DIABETIC NEUROPATHY
Source text for Eikon: ID:nPn66dTx0a
Further company coverage: NVRO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nevro
See all newsNevro Corp reports results for the quarter ended December 31 - Earnings Summary
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 78 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro